Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Gazzard

Showing results (181-190 of 206) with videos related to

Pageof 21
Sort By:
Plos Medicine|November 5, 2004
Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1Frank van Leth, Prahpan Phanuphak, Erik Stroes, et al.
AIDS (London, England)|September 12, 2008
Treatment switches after viral rebound in HIV-infected adults starting antiretroviral therapy: multicentre cohort study, Katherine J Lee, David Dunn, et al.
AIDS (London, England)|August 11, 2007
Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell countAndrew N Phillips, Brian Gazzard, Richard Gilson, et al.
Haematologica|April 2, 2009
CD4 counts and the risk of systemic non-Hodgkin's lymphoma in individuals with HIV in the UKMark Bower, Martin Fisher, Teresa Hill, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 25, 2008
Determination of clinically relevant cutoffs for HIV-1 phenotypic resistance estimates through a combined analysis of clinical trial and cohort dataBart Winters, Julio Montaner, P Richard Harrigan, et al.
Journal of the International Association of Providers of AIDS Care|May 14, 2013
Controlling the HIV epidemic with antiretrovirals: IAPAC consensus statement on treatment as prevention and preexposure prophylaxisKenneth Mayer, Brian Gazzard, José M Zuniga, et al.
European Journal of Neurology|December 17, 2010
HIV-associated central nervous system diseases in the recent combination antiretroviral therapy era, Lucy Garvey, Alan Winston, et al.
AIDS (London, England)|September 23, 2009
Tuberculosis among people with HIV infection in the United Kingdom: opportunities for prevention?Alison D Grant, Loveleen Bansi, Jonathan Ainsworth, et al.
The Journal of Antimicrobial Chemotherapy|February 26, 2013
Effects of age on antiretroviral plasma drug concentration in HIV-infected subjects undergoing routine therapeutic drug monitoringAlan Winston, Sophie Jose, Sara Gibbons, et al.
Blood|April 14, 2005
Conservation of unique cell-surface CD antigen mosaics in HIV-1-infected individualsAdrian Woolfson, Justin Stebbing, Brian D M Tom, et al.
Pageof 21

Showing results (181-190 of 206) with videos related to

Sort By:
Pageof 21
Plos Medicine|November 5, 2004
Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1Frank van Leth, Prahpan Phanuphak, Erik Stroes, et al.
AIDS (London, England)|September 12, 2008
Treatment switches after viral rebound in HIV-infected adults starting antiretroviral therapy: multicentre cohort study, Katherine J Lee, David Dunn, et al.
AIDS (London, England)|August 11, 2007
Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell countAndrew N Phillips, Brian Gazzard, Richard Gilson, et al.
Haematologica|April 2, 2009
CD4 counts and the risk of systemic non-Hodgkin's lymphoma in individuals with HIV in the UKMark Bower, Martin Fisher, Teresa Hill, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 25, 2008
Determination of clinically relevant cutoffs for HIV-1 phenotypic resistance estimates through a combined analysis of clinical trial and cohort dataBart Winters, Julio Montaner, P Richard Harrigan, et al.
Journal of the International Association of Providers of AIDS Care|May 14, 2013
Controlling the HIV epidemic with antiretrovirals: IAPAC consensus statement on treatment as prevention and preexposure prophylaxisKenneth Mayer, Brian Gazzard, José M Zuniga, et al.
European Journal of Neurology|December 17, 2010
HIV-associated central nervous system diseases in the recent combination antiretroviral therapy era, Lucy Garvey, Alan Winston, et al.
AIDS (London, England)|September 23, 2009
Tuberculosis among people with HIV infection in the United Kingdom: opportunities for prevention?Alison D Grant, Loveleen Bansi, Jonathan Ainsworth, et al.
The Journal of Antimicrobial Chemotherapy|February 26, 2013
Effects of age on antiretroviral plasma drug concentration in HIV-infected subjects undergoing routine therapeutic drug monitoringAlan Winston, Sophie Jose, Sara Gibbons, et al.
Blood|April 14, 2005
Conservation of unique cell-surface CD antigen mosaics in HIV-1-infected individualsAdrian Woolfson, Justin Stebbing, Brian D M Tom, et al.
Pageof 21